SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-192223
Filing Date
2009-09-15
Accepted
2009-09-15 17:23:02
Documents
9
Period of Report
2009-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19065
2 FORM OF WARRANT dex41.htm EX-4.1 77472
3 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP dex51.htm EX-5.1 8478
4 FORM OF SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 140936
5 LETTER AGREEMENT DATED SEPTEMBER 10, 2009 dex102.htm EX-10.2 78807
6 PRESS RELEASE dex991.htm EX-99.1 8565
7 GRAPHIC g86691g19t01.jpg GRAPHIC 17071
8 GRAPHIC g86691g25k74.jpg GRAPHIC 7861
9 GRAPHIC g86691g68p83.jpg GRAPHIC 6437
  Complete submission text file 0001193125-09-192223.txt   378891
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 091070634
SIC: 2836 Biological Products, (No Diagnostic Substances)